Pharmaceutical Care of People with Atrial Fibrillation. Course activities

Similar documents
Pharmaceutical Care of people with heart failure. Course activities

Pharmaceutical Care of People with Atrial Fibrillation. Course information

Pharmaceutical care of patients with infections. Course activities

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Atrial fibrillation and anticoagulation therapy

Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

MRCP(UK) PACES. INFORMATION FOR THE CANDIDATE Training Scenario N 001 SAMPLE HOST CENTRE Station 5: BRIEF CLINICAL CONSULTATION

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

Medical Apps for Cardiology Uses. There s an App for That!

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

Cardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention

Atrial fibrillation. Understanding NICE guidance

beclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite))

Medications and your Heart. RBCH Foundation Trust

Pathology Service User Guide Haematology

PHARMACOLOGICAL PROBLEMS

Cardiac Rehabilitation. Questions and Answers Information for Patients

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

THE TESTIMONY OF DOCTOR.ONYIA FROM BVM HOSPITAL, OLODI-APAPA

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography

ARTIC PC. Diagnosis & treatment study Diary. Version 1 ( )

Medicines for high blood pressure

Associate Professor Gerry Devlin

A Cardiologist s Guide to Love

Atrial Fibrillation Topics for Today. Clinical Controversies Management of Atrial Fibrillation. Atrial Fibrillation in the ER Topics for Today

Sandwell Community Heart Failure Team. Community Heart failure Specialist Nurses: Hilda O Keeffe- Henry and Jacqui Elson-Whittaker

NOAC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form

Introduction. What atrial fibrillation (AF) is Warning signs & symptoms, and risk factors for developing AFrelated

Patient Encounters in the Primary Care Setting

APPLICATION FOR PODIATRY ASSESSMENT

Dear Patient: We look forward to seeing you! Please call us at (423) should you have any questions.

Blood-thinning medication after stroke

Cases & Panel Discussion

What is the next best step in management?

Atrial Fibrillation and Anticoagulants

This information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126.

Diploma in Geriatric Medicine Sample Questions

CLINICAL THERAPEUTICS 2: CARDIOVASCULAR AND RENAL DISEASE (PHAB3FLY)

Variables in Riksstroke - TIA

Pharmaceutical care of stroke patients Course information

Helping to prevent stroke caused by non-valvular atrial fibrillation Information booklet

CVD Outcomes Aggregate Report Report Period: 05/01/ /30/2004

Tricky Cases in Primary Care Anticoagulation in AF

Possible Cardiovascular System Abnormality. Opening and closing of a coronary artery Inflammation of the outside lining of the heart

Information in these slides is used with permission from St. Mary s Cardiac Rehab

11/4/2017. but cocaine toxicity is complex: Pro thrombotic effects Progressive atherosclerosis Ventricular remodeling

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008

NES Asthma Hospital Medication Care Plan 7

I (312) Mitral Regurgitation What Should You Know?

Antihypertensive drugs: I. Thiazide and other diuretics:

Atrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist

Aspirin for the Prevention of Cardiovascular Disease


Atrial Fibrillation Management in the ED. J Fisher May 2014"

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency

Health Talk with your partner about a time when you were sick Discuss:

Direct Current (DC) Cardioversion

Warfarin PATIENT EDUCATION

After your angiogram or angioplasty

Fibrillation. Living. withatrial. Further information

5AB Dysrhythmia Interpretation and Management 2016

After Your Angioplasty: Radial Artery Approach

Pharmaceutical care of stroke patients Course information

Adherence to VKA treatments : What are the needs?

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care

NEW PATIENT VISIT QUESTIONNAIRE

Management strategies for atrial fibrillation Thursday, 20 October :27

Baseline hospital survey

Date: / / Hello, my name is [interviewer name], and I'm calling to speak with [participant name]. Is [participant name] available?

Edoxaban Switch Programme - Frequently Asked Questions

t. Recommendations for periprocedural anticoagulation are available lhrough the American College of Chest Physicians Clinical Practice Guidelines.

Name of Pa. tient: Last. First. per day) 50 mg. X-ray dye or. IV contract. Name (Last) (First) Address. City, state/ zip code

THE CARDIOVASCULAR SYSTEM-PART 2

Aspirin as a Tool to Improve Heart Health Now! 1 Aspirin as a Tool to Improve Heart Health Now!

Repeat Dispensing Handbook

Before you start go to page 2. Leeds West Clinical Commissioning Group

Analysing Apixaban: Potential Growth Driver for Pfizer and Bristol Myers Squibb. Tro Kalayjian Chief Medical Analyst Chimera Research Group

Blood Thinning in Atrial Fibrillation (AF)

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Candidate number BOOK TWO. NSW Fellowship Course - SAQ trial paper

Banner Health Center

Summary of the risk management plan (RMP) for Ivabradine Anpharm (ivabradine)

Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients?

Atrial Fibrillation and Options to Reduce Your Risk of Blood Clots and Stroke

CORONARY ANGIOPLASTY

Low risk upper GI bleeding pathway

Blood-thinning medication after stroke

Understanding our advice ~ December The use of troponin testing in acute coronary syndromes

Transcatheter Aortic Valve Implantation (TAVI) PROOF. Patient Information leaflet. Lancashire Cardiac Centre

Transoesophageal echocardiogram (TOE)

DIVISION OF CARDIOLOGY

Closing your atrial septal defect without surgery

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Summary of safety concerns Important identified risks

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Pharmaceutical care of people with chronic pain Course activities. Case study 1

Arrhythmias. A/Prof Drew Richardson. The Canberra Hospital May MB BS (Hons) FACEM Grad CertHE MD

Transcription:

Pharmaceutical Care of People with Atrial Fibrillation Course activities

Pharmaceutical Care of People with Atrial Fibrillation Course activities page 3 Case Study 1 5 Case Study 2 7 Case Study 3 9 Case Study 4

Case Study 1 Jim King, a 59-year-old man, has recently been discharged from hospital following an admission due to breathlessness and palpitations. An electrocardiogram confirmed fast atrial fibrillation and an echocardiogram showed a dilated left atrium and mitral stenosis. His past medical history includes hypertension treated with amlodipine 5mg a day. He was also on aspirin 75mg a day and simvastatin 40mg a day. He presents to your community pharmacy with a prescription for: bisoprolol 5mg a day warfarin 1mg and 3mg tablets as per INR simvastatin 40mg at night Mr King Mr King Mr King Hello, Mr King, I hear you have been in hospital. How are you now? Not bad now. I had to go in because my heart was racing and I felt light-headed and breathless. I see they have changed your tablets. Yes. I ve been put on two new tablets. I don t know what I ve to do about the tablets I was on before. Have you to go back to the hospital clinic? Yes, I have an appointment next week to have my blood tested and another appointment in a month to see the cardiologist. 3 Pharmaceutical care of people with Atrial Fibrillation Course activities

Discussion points Case Study 1 What is the rationale for the new medicines? What monitoring is required for these medicines? What advice would you offer Mr King regarding these medicines? What are the likely reasons for discontinuing the amlodipine and aspirin? 4 Pharmaceutical care of people with Atrial Fibrillation Course activities

Case Study 2 Mrs Kathy Young is a 61-year-old woman with a long history of angina and asthma. Last year she was also diagnosed has having atrial fibrillation. Her current medication consists of: GTN spray 2 puffs as required aspirin 75mg daily amlodipine 5mg daily simvastatin 40mg daily digoxin 0.25mg daily Mrs Young Mrs Young Hello, Mrs Young, how are you? Not too bad, but I have felt my heart racing a bit recently. Have you seen Dr Brown about it? Yes, I saw him this morning. He has started me on another tablet. 5 Pharmaceutical care of people with Atrial Fibrillation Course activities

Discussion points Case Study 2 What is the likely additional rate control therapy and what factors would affect the choice? What impact would this choice have on her current medication? What other information would be useful? Should she be on warfarin and if so, why? 6 Pharmaceutical care of people with Atrial Fibrillation Course activities

Case Study 3 Mr Tom Hughes, a 68-year-old gentleman with a past medical history of asthma and mixed valve disease has recently been diagnosed with atrial fibrillation. He is currently treated with verapamil c/r 240mg daily and warfarin, dose as per International Normalised Ratio (INR). He comes into your community pharmacy to collect his prescription. Mr Hughes Mr Hughes Mr Hughes Mr Hughes Mr Hughes Hello, Tom, how are you today? Fine, but it s a bit of a hassle having to go for these blood tests all the time. I know, but it is important that we get the dose of the warfarin right. So they tell me, but I can t always make it. Have you missed any appointments recently? The last one I was at was a month ago. What was the INR result then? I think it was 2.7, less than 3 anyway. Have you noticed any bleeding or bruising? I still bruise a bit, but no bleeding. I have noticed that when I go to the toilet; my stools are much darker than usual. 7 Pharmaceutical care of people with Atrial Fibrillation Course activities

Discussion points Case Study 3 What are the possible causes of dark stools? What are the possible causes of high INR results? What are the other possible bleeding foci? What would you tell Mr Hughes to do? 8 Pharmaceutical care of people with Atrial Fibrillation Course activities

Case Study 4 Ms Jane Clark is a 46-year-old woman who has a 10-year history of hypertension. She has recently been admitted to hospital with a myocardial infarction complicated by new onset atrial fibrillation. Her current medication is: aspirin 75mg daily simvastatin 40mg daily atenolol 100mg daily GTN spray as required for chest pain Ms Clark Ms Clark, I hear you have been in hospital? Yes, but feel fine now. I had a heart attack and now I ve got to take tablets to slow my heart down and help it work better. What have they put you on? Ms Clark gives you a prescription for: aspirin 75mg daily digoxin 0.25mg daily simvastatin 40mg daily furosemide 40mg daily ramipril 2.5mg twice daily warfarin as per INR GTN spray as required for chest pain Ms Clark Ms Clark I see they have stopped your atenolol. Yes, but I don t know why, I ve been on that for years. How have you been since you got home? Not too bad. I ve started doing a bit more exercise and sometimes I feel my heart racing. I feel OK if I have a rest though. 9 Pharmaceutical care of people with Atrial Fibrillation Course activities

Discussion points Case Study 4 Why has Ms Clark developed atrial fibrillation? What is the rationale for: a. the choice of rate control therapy? b. the combination of aspirin and warfarin? How would you account for the recent episodes of uncontrolled heart rate? What are the pharmaceutical care issues relating to atrial fibrillation in this patient? 10 Pharmaceutical care of people with Atrial Fibrillation Course activities

NHS Education for Scotland (Pharmacy) 3rd Floor, 2 Central Quay 89 Hydepark Street Glasgow G3 8BW Tel: 0141 223 1600 Fax: 0141 223 1651 www.nes.scot.nhs.uk/pharmacy